MMCM
BMY icon

Murphy & Mullick Capital Management’s Bristol-Myers Squibb BMY Stock Holding History

Murphy & Mullick Capital Management’s Portfolio BMY Stock Details BMY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$240K Buy
3,954
+646
+20% +$37.7K 0.18% 118
2025
Q4 		$178K Sell
3,308
-762
-19% -$36.7K 0.13% 151
2025
Q3 		$184K Sell
4,070
-865
-18% -$40.4K 0.14% 147
2025
Q2 		$215K Sell
4,935
-503
-9% -$24.7K 0.17% 122
2025
Q1 		$332K Buy
5,438
+2
+0% +$117 0.32% 74
2024
Q4 		$307K Buy
+5,436
New +$304K 0.28% 84

Other funds holding BMY

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Murphy & Mullick Capital Management's BMY Position: Q1 2026 in Review

Murphy & Mullick Capital Management increased its Bristol-Myers Squibb (BMY) stake by 20% in Q1 2026, buying an estimated $37.7K and bringing the position to 3,954 shares worth $240K. The position accounts for 0.18% of the portfolio, ranked #118.

Murphy & Mullick Capital Management first reported a position in BMY in Q4 2024 and has held it in 6 quarters since. The position peaked at $332K in Q1 2025. 2,517 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Murphy & Mullick Capital Management held 3,954 shares of Bristol-Myers Squibb worth $240K as of Q1 2026.
  • Murphy & Mullick Capital Management bought 646 Bristol-Myers Squibb shares in Q1 2026, an estimated $37.7K.
  • Bristol-Myers Squibb made up 0.18% of Murphy & Mullick Capital Management's portfolio in Q1 2026, its #118 holding.
  • Murphy & Mullick Capital Management first reported a position in Bristol-Myers Squibb in Q4 2024 and has held it in 6 quarters since.
  • Murphy & Mullick Capital Management's Bristol-Myers Squibb position peaked at $332K in Q1 2025.
  • 2,517 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Murphy & Mullick Capital Management's 13F filing for Q1 2026, filed 17 Apr 2026.